- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Balance Sheet: Assets
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
| 12 months ended: | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Federal | |||||||||||
| State | |||||||||||
| Domestic | |||||||||||
| Foreign | |||||||||||
| Current | |||||||||||
| Federal | |||||||||||
| State | |||||||||||
| Domestic | |||||||||||
| Foreign | |||||||||||
| Deferred | |||||||||||
| Taxes on earnings |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The income tax expense (benefit) exhibits significant fluctuations over the five-year period. Current tax expense generally increased from 2021 to 2022, then decreased in 2023, followed by a moderate increase in 2024, and a slight decrease in 2025. Deferred tax expense (benefit) demonstrates a more volatile pattern, shifting from expense to a substantial benefit in 2025. The combined effect, reflected in "Taxes on earnings," reveals a considerable net tax expense in the initial years, a large net tax benefit in 2024, and a return to net tax expense in 2025.
- Current Tax Expense
- Current tax expense increased from US$1,649 million in 2021 to US$2,032 million in 2022, representing a growth of approximately 23.2%. A subsequent decrease to US$1,402 million in 2023 indicates a reduction of roughly 31.0% from the prior year. This was followed by a modest increase to US$1,572 million in 2024, and a slight decline to US$1,501 million in 2025. The fluctuations suggest a correlation with changes in pre-tax income, though further investigation would be required to confirm this relationship.
- Deferred Tax Expense (Benefit)
- Deferred tax expense was consistently negative, representing a deferred tax benefit, from 2021 to 2023. The benefit decreased from US$509 million in 2021 to US$659 million in 2022, and then slightly decreased to US$461 million in 2023. However, 2024 saw a dramatic shift, with a substantial deferred tax expense of US$7,961 million. This was reversed in 2025, resulting in a deferred tax benefit of US$441 million. This large swing indicates significant changes in temporary differences between book and tax bases of assets and liabilities, or changes in tax laws and rates.
- Taxes on Earnings
- The "Taxes on earnings" line, representing the total income tax expense (benefit), reflects the combined impact of current and deferred taxes. A net expense of US$1,140 million was recorded in 2021, increasing to US$1,373 million in 2022. This decreased to US$941 million in 2023. The most notable change occurred in 2024, where a significant net benefit of US$6,389 million was recorded, largely driven by the deferred tax expense. In 2025, the line returned to a net expense of US$1,942 million, indicating a reversal of the benefit experienced in the previous year. The volatility in this line suggests substantial changes in the company’s taxable income and deferred tax position.
The substantial deferred tax expense in 2024 warrants further scrutiny to understand the underlying causes. The shift back to a net tax expense in 2025, after the large benefit in 2024, suggests a temporary impact from the 2024 deferred tax expense. Overall, the income tax expense (benefit) demonstrates considerable variability, requiring a detailed understanding of the company’s tax strategy and the applicable tax regulations.
Effective Income Tax Rate (EITR)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| U.S. federal statutory tax rate | ||||||
| Effective tax rate |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The effective income tax rate exhibits considerable fluctuation over the observed period. While the U.S. federal statutory tax rate remained constant at 21.00% throughout the years presented, the effective tax rate demonstrates significant variance.
- Effective Tax Rate Trend
- In 2021, the effective tax rate was 13.90%. This increased to 16.50% in 2022, suggesting a potential shift in the composition of income or changes in tax planning strategies. A subsequent decrease to 14.10% occurred in 2023, indicating a possible reversal of the factors driving the 2022 increase. However, 2024 witnessed a dramatic decline, resulting in a negative effective tax rate of -91.10%. This substantial decrease is atypical and warrants further investigation, potentially stemming from significant tax benefits, one-time adjustments, or changes in the geographic distribution of earnings. The effective tax rate rebounded sharply in 2025, reaching 22.90%, approaching the statutory rate. This suggests the factors influencing the 2024 rate were largely non-recurring.
The considerable divergence between the effective tax rate and the statutory tax rate across the period highlights the impact of various factors influencing the company’s tax obligations. These factors could include tax credits, deductions, foreign income, and changes in tax laws. The negative effective tax rate in 2024 is a particularly noteworthy event requiring detailed scrutiny to understand its underlying causes and potential implications.
- Variance from Statutory Rate
- The effective tax rate consistently differed from the statutory rate, indicating the presence of permanent or temporary differences between taxable income and accounting income. The largest deviation occurred in 2024, where the negative effective tax rate represented a 112.10 percentage point difference from the 21.00% statutory rate. The 2025 rate, while positive, still showed a 0.90 percentage point difference from the statutory rate.
Continued monitoring of the effective tax rate and its components is recommended to assess the sustainability of the observed trends and to identify potential risks or opportunities related to tax planning and compliance.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The composition of deferred tax assets and liabilities exhibits significant fluctuations over the five-year period. A notable increase in deferred tax assets is observed, driven primarily by changes in the valuation allowance and, to a lesser extent, specific deferred tax asset components. Deferred tax liabilities demonstrate a relatively stable, albeit negative, balance throughout the period.
- Deferred Tax Asset Components
- The largest component of deferred tax assets consistently stems from net operating losses (NOLs), reserves not currently deductible, and credit carryforwards. This component experienced a substantial surge in 2023 and 2024, increasing from US$2,425 million to US$10,353 million, before decreasing slightly to US$9,730 million in 2025. Compensation and employee benefits also contribute significantly, though with more volatility, peaking at US$230 million in 2022 before declining to negligible amounts in later years. Research and development costs emerge as a substantial component starting in 2022, growing consistently to US$902 million by 2025. Trade receivable reserves and inventory reserves remain relatively stable contributors. Lease liabilities show minor fluctuations. Deferred intercompany profit also contributes consistently.
- Valuation Allowance
- The valuation allowance against deferred tax assets initially remained relatively consistent at approximately US$-1,170 million between 2021 and 2022. However, a dramatic increase to US$-8,690 million occurred in 2023, coinciding with the significant rise in NOLs and other deferred tax assets. This allowance decreased substantially in 2024 and 2025 to US$-1,664 million and US$-1,771 million respectively, suggesting increased confidence in the realizability of these deferred tax assets. The changes in the valuation allowance have a substantial impact on the reported deferred tax asset balance.
- Deferred Tax Liability Components
- Deferred tax liabilities are primarily driven by other items, specifically the excess of book basis over tax basis of intangible assets, which consistently represents the largest portion. Depreciation and right-of-use lease assets also contribute to deferred tax liabilities, though to a lesser extent. Compensation and employee benefits become a liability component starting in 2024, increasing in magnitude over time. Overall, deferred tax liabilities remain relatively stable, ranging between US$-2,666 million and US$-2,328 million throughout the period.
- Net Deferred Tax Position
- The net deferred tax position transitions from a net liability of US$-186 million in 2021 to a substantial net asset of US$8,111 million in 2024, and US$7,505 million in 2025. This shift is primarily attributable to the significant increase in deferred tax assets, coupled with the changes in the valuation allowance and the relatively stable deferred tax liabilities. The substantial change in 2023 and 2024 indicates a significant impact on the company’s future tax obligations.
In summary, the deferred tax asset and liability balances are dynamic, with significant changes occurring in 2023 and 2024. The primary driver of these changes is the fluctuation in NOLs and the corresponding adjustments to the valuation allowance. The company’s net deferred tax position has shifted dramatically from a net liability to a substantial net asset over the observed period.
Deferred Tax Assets and Liabilities, Classification
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Deferred tax assets | ||||||
| Deferred tax liabilities |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The deferred tax asset and liability positions exhibited notable fluctuations over the five-year period. A significant increase in deferred tax assets occurred in 2023, followed by a slight decrease in 2024 and 2025. Deferred tax liabilities consistently decreased from 2021 to 2023, then stabilized with minor changes in the subsequent two years.
- Deferred Tax Assets
- Deferred tax assets decreased from US$1,206 million in 2021 to US$1,044 million in 2022, representing a decline of approximately 13.4%. A further decrease to US$982 million was observed in 2023. However, a substantial increase occurred in 2024, with deferred tax assets rising to US$8,623 million. This increase was partially moderated in 2025, with a balance of US$8,064 million. The large increase in 2024 suggests a significant change in temporary differences or carryforwards impacting future tax benefits.
- Deferred Tax Liabilities
- Deferred tax liabilities experienced a consistent decline from US$1,392 million in 2021 to US$568 million in 2023. This represents a reduction of approximately 59.3% over the three-year period. The decline slowed in 2024 and 2025, with balances of US$512 million and US$559 million, respectively. The stabilization in deferred tax liabilities suggests a potential leveling off of temporary differences creating taxable amounts in the future.
- Net Deferred Tax Position
- In 2021, the net deferred tax position (liabilities less assets) was US$186 million. This position shifted to a net asset of US$47 million in 2022, and a net asset of US$414 million in 2023. The substantial increase in deferred tax assets in 2024 resulted in a significant net asset position of US$8,111 million, which slightly decreased to US$7,505 million in 2025. The overall trend indicates a move from a net deferred tax liability to a substantial net deferred tax asset.
The considerable changes in deferred tax assets, particularly the increase in 2024, warrant further investigation to understand the underlying causes. These changes could be related to acquisitions, changes in tax laws, or adjustments to valuation allowances. The stabilization of deferred tax liabilities suggests a potential reduction in future taxable temporary differences.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial information reveals adjustments made to reported figures, primarily relating to the removal of deferred tax assets and liabilities. These adjustments consistently impact total assets, total liabilities, and shareholders’ investment over the five-year period. A consistent pattern emerges where reported values are higher than their adjusted counterparts, indicating a reduction in reported figures upon removing deferred tax effects.
- Total Assets
- Reported total assets experienced a decline from 2021 to 2023, followed by substantial increases in 2024 and 2025. The adjusted total assets mirror this trend, though the magnitude of the increase in later years is comparatively smaller. The difference between reported and adjusted total assets remains relatively stable, fluctuating between approximately US$1.2 billion and US$1.9 billion annually.
- Total Liabilities
- Reported total liabilities demonstrate a decreasing trend from 2021 to 2024, with a slight increase in 2025. Adjusted total liabilities follow a similar pattern, consistently lower than reported liabilities. The gap between the two figures remains relatively consistent, ranging from approximately US$1.4 billion to US$1.5 billion throughout the period.
- Shareholders’ Investment
- Reported total shareholders’ investment shows an increasing trend throughout the period, with a significant jump between 2023 and 2024. Adjusted shareholders’ investment also increases, but at a slower pace, particularly in 2024. The difference between reported and adjusted shareholders’ investment is comparatively smaller than the differences observed in assets and liabilities, generally ranging between US$0.05 billion and US$0.56 billion.
- Net Earnings
- Reported net earnings fluctuate considerably. A decrease is observed from 2021 to 2023, followed by a substantial increase in 2024 and a decrease in 2025. Adjusted net earnings exhibit a similar pattern, though the magnitude of the changes is generally less pronounced. The adjustment consistently reduces reported net earnings, with the difference ranging from approximately US$0.48 billion to US$0.66 billion annually.
The consistent adjustments to all reported figures suggest a significant impact from deferred tax items. The relatively stable differences between reported and adjusted values indicate a systematic removal of these deferred taxes. The impact on net earnings is notable, suggesting that deferred tax effects contribute materially to the reported profitability of the entity.
Abbott Laboratories, Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial performance, as indicated by a set of key ratios, exhibits notable variations when deferred tax impacts are removed, resulting in adjusted figures. Generally, the adjusted ratios demonstrate a more conservative view of profitability and returns compared to their reported counterparts. A significant fluctuation in reported profitability is observed in 2024, which is substantially moderated when considering the adjusted metrics.
- Profitability
- Reported net profit margin peaked in 2021 at 16.42% before declining to 14.27% in 2023. A substantial increase to 31.95% occurred in 2024, followed by a decrease to 14.72% in 2025. The adjusted net profit margin shows a more consistent, albeit downward, trend from 15.23% in 2021 to 13.12% in 2023, with a modest recovery to 15.71% in 2025. The difference between reported and adjusted margins highlights the influence of deferred tax assets or liabilities on reported earnings, particularly in 2024.
- Asset Utilization
- Reported total asset turnover remained relatively stable between 0.57 and 0.59 from 2021 to 2022, then decreased to 0.55 in 2023 and further to 0.51 in 2025. The adjusted total asset turnover mirrors this trend, showing a slight increase in 2022, a decline in 2023, and a stabilization around 0.56-0.58. The impact of deferred taxes on asset turnover is minimal, with adjusted values consistently close to reported values.
- Financial Leverage
- Reported financial leverage decreased steadily from 2.10 in 2021 to 1.66 in 2025. The adjusted financial leverage follows a similar pattern, declining from 2.06 to 1.76 over the same period. The adjustment for deferred taxes results in a slightly lower leverage ratio, suggesting a reduced reliance on debt financing when these items are excluded. The magnitude of the difference is relatively small.
- Returns on Equity and Assets
- Reported ROE experienced a decline from 19.75% in 2021 to 14.83% in 2023, followed by a significant jump to 28.12% in 2024 and a subsequent drop to 12.51% in 2025. The adjusted ROE demonstrates a more moderate decline from 18.23% to 13.78% between 2021 and 2023, with a slight increase to 15.61% in 2025. The substantial difference in 2024 underscores the impact of deferred taxes on reported equity returns. A similar pattern is observed in ROA, with reported values fluctuating more dramatically than adjusted values. Reported ROA peaked at 16.46% in 2024, while the adjusted ROA remained below 8% throughout the period, peaking at 8.86% in 2025.
In summary, the removal of deferred tax effects provides a more stable and conservative assessment of financial performance. The significant discrepancies observed in 2024 for profitability and returns suggest that deferred taxes played a substantial role in the reported results for that year. The adjusted ratios offer a potentially more representative view of underlying operational performance, excluding the timing differences associated with tax accounting.
Abbott Laboratories, Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Net profit margin = 100 × Net earnings ÷ Net sales
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net earnings ÷ Net sales
= 100 × ÷ =
The period under review demonstrates fluctuations in both reported and adjusted net earnings, consequently impacting associated profit margins. While reported net earnings exhibit significant volatility, the adjusted net profit margin presents a more stable, though evolving, picture of underlying profitability.
- Adjusted Net Profit Margin Trend
- The adjusted net profit margin decreased from 15.23% in 2021 to 13.12% in 2023, indicating a consistent, two-year decline in profitability after adjustments. This downward trend suggests increasing costs or decreasing revenues not fully captured in reported earnings. A slight recovery to 12.97% is observed in 2024, but this remains below the 2021 level. A notable increase to 15.71% occurs in 2025, bringing the adjusted net profit margin closer to, but still slightly above, the 2021 figure.
- Relationship to Reported Net Profit Margin
- The adjusted net profit margin consistently falls below the reported net profit margin across all years. This difference suggests that certain items included in reported net earnings are being excluded in the adjusted calculation, likely related to one-time gains or accounting adjustments. The largest disparity is seen in 2024, where the reported net profit margin reaches a high of 31.95%, significantly exceeding the adjusted margin of 12.97%. This indicates a substantial impact from items excluded in the adjusted figure during that year.
- Volatility and Recovery
- The period between 2021 and 2024 shows a general decline in adjusted profitability, followed by a recovery in 2025. The 2025 increase in the adjusted net profit margin is a positive development, potentially signaling improved operational efficiency or a more favorable business environment. However, the return to a level only modestly above that of 2021 warrants further investigation to determine the sustainability of this improvement.
In summary, the adjusted net profit margin demonstrates a period of decline followed by a recovery, with consistent differences observed when compared to the reported net profit margin. The significant variation in 2024 highlights the importance of understanding the specific adjustments made to arrive at the adjusted figures.
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= ÷ =
The analysis reveals trends in both reported and adjusted total assets, alongside their corresponding turnover ratios, over a five-year period. Reported total assets experienced a slight decrease from 2021 to 2023, followed by increases in 2024 and 2025. Adjusted total assets mirrored this pattern, exhibiting a similar decrease initially and subsequent increases. The adjusted total asset turnover ratio demonstrates relative stability compared to the reported ratio.
- Reported Total Assets
- Reported total assets decreased from US$75,196 million in 2021 to US$73,214 million in 2023, representing a cumulative decline. A subsequent recovery is observed, with assets increasing to US$81,414 million in 2024 and further to US$86,713 million in 2025. This indicates a period of asset reduction followed by reinvestment or acquisition activity.
- Adjusted Total Assets
- Adjusted total assets followed a similar trajectory to reported total assets, declining from US$73,990 million in 2021 to US$72,232 million in 2023. Increases were then noted in 2024 (US$72,791 million) and 2025 (US$78,649 million). The adjusted figures are consistently lower than the reported figures, suggesting potential adjustments related to specific asset valuations or classifications.
- Reported Total Asset Turnover
- The reported total asset turnover ratio fluctuated over the period. It began at 0.57 in 2021, rose to 0.59 in 2022, then decreased to 0.55 in 2023 and 0.52 in 2024. A slight increase to 0.51 is observed in 2025. This suggests a varying efficiency in generating sales from the company’s asset base, with a general downward trend over the analyzed timeframe.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio exhibited more stability than the reported ratio. It remained at 0.58 in both 2021 and 2022, decreased to 0.56 in 2023, increased to 0.58 in 2024, and then decreased slightly to 0.56 in 2025. The consistency suggests that the adjustments to total assets do not significantly alter the core measure of asset utilization efficiency.
The slight divergence between the reported and adjusted turnover ratios indicates that the asset adjustments impact the reported figures, but the underlying operational efficiency, as measured by the adjusted ratio, remains relatively consistent. The overall trend suggests a modest decline in asset utilization efficiency when considering the reported figures, while the adjusted figures show a more stable performance.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Total Abbott shareholders’ investment
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Abbott shareholders’ investment
= ÷ =
The information presents a five-year trend of total assets, shareholders’ investment, and associated financial leverage ratios, both reported and adjusted. A general observation is that both reported and adjusted total assets experienced fluctuations, while shareholders’ investment consistently increased over the period. The financial leverage ratios demonstrate a decreasing trend across the five years, suggesting a reduction in the company’s reliance on financial leverage.
- Total Assets
- Reported total assets decreased from US$75,196 million in 2021 to US$73,214 million in 2023, before increasing to US$81,414 million in 2024 and further to US$86,713 million in 2025. Adjusted total assets followed a similar pattern, declining initially and then increasing in the later years. The difference between reported and adjusted total assets remained relatively consistent throughout the period, indicating a systematic adjustment being applied.
- Shareholders’ Investment
- Reported total shareholders’ investment exhibited a steady increase from US$35,802 million in 2021 to US$52,130 million in 2025. The adjusted total shareholders’ investment also increased consistently, mirroring the trend of the reported figures. The adjustment to shareholders’ investment appears to be a minor downward correction each year.
- Reported Financial Leverage
- Reported financial leverage decreased from 2.10 in 2021 to 1.66 in 2025. This indicates a reduction in the proportion of assets financed by equity. The decline was most pronounced between 2021 and 2023, with a more gradual decrease in the subsequent years.
- Adjusted Financial Leverage
- Adjusted financial leverage mirrored the trend of the reported ratio, decreasing from 2.06 in 2021 to 1.76 in 2025. The adjusted leverage ratio consistently remained slightly lower than the reported ratio across all years, suggesting the adjustments to assets and shareholders’ investment contribute to a lower leverage profile. The magnitude of the difference between the reported and adjusted leverage remained relatively stable.
In summary, the company experienced growth in shareholders’ investment alongside fluctuations in total assets. Both reported and adjusted financial leverage ratios demonstrate a consistent downward trend, indicating a strengthening of the company’s financial position with decreasing reliance on financial leverage over the observed period.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net earnings ÷ Total Abbott shareholders’ investment
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net earnings ÷ Adjusted total Abbott shareholders’ investment
= 100 × ÷ =
The period under review demonstrates fluctuations in both reported and adjusted net earnings, alongside consistent growth in total shareholders’ investment. These movements impact calculated returns on equity, both as reported and adjusted. A comparison of these metrics reveals differences arising from adjustments made to net earnings and shareholders’ investment.
- Reported Net Earnings & ROE
- Reported net earnings decreased from US$7,071 million in 2021 to US$6,933 million in 2022, then experienced a more substantial decline to US$5,723 million in 2023. A significant increase was observed in 2024, reaching US$13,402 million, followed by a decrease to US$6,524 million in 2025. Correspondingly, reported ROE mirrored this trend, declining from 19.75% in 2021 to 18.90% in 2022 and 14.83% in 2023. The substantial increase in net earnings in 2024 drove reported ROE to a high of 28.12%, but it subsequently decreased to 12.51% in 2025.
- Adjusted Net Earnings & ROE
- Adjusted net earnings followed a similar pattern to reported net earnings, decreasing from US$6,562 million in 2021 to US$6,274 million in 2022 and US$5,262 million in 2023. While an increase occurred in 2024, it was less pronounced than the reported figures, reaching US$5,441 million, before rising to US$6,965 million in 2025. Adjusted ROE decreased from 18.23% in 2021 to 17.13% in 2022 and 13.78% in 2023. It remained relatively stable at 13.76% in 2024 and increased to 15.61% in 2025.
- Shareholders’ Investment
- Both reported and adjusted total shareholders’ investment exhibited a consistent upward trend throughout the period. Reported investment increased from US$35,802 million in 2021 to US$52,130 million in 2025. Adjusted investment also increased, from US$35,988 million in 2021 to US$44,625 million in 2025, though at a slower pace than the reported investment.
- ROE Discrepancies
- The difference between reported and adjusted ROE varied across the period. The largest divergence occurred in 2024, where reported ROE (28.12%) significantly exceeded adjusted ROE (13.76%). This suggests that adjustments to net earnings and shareholders’ investment had a substantial impact on the calculated return in that year. In other years, the difference between the two ROE figures was less pronounced, indicating a smaller effect from the adjustments.
The observed fluctuations in net earnings, coupled with the consistent growth in shareholders’ investment, resulted in dynamic changes in both reported and adjusted ROE. The adjustments made to net earnings and shareholders’ investment consistently resulted in a lower ROE compared to the reported figures, with the magnitude of the difference varying annually.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net earnings ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net earnings ÷ Adjusted total assets
= 100 × ÷ =
The period under review demonstrates fluctuating performance in reported and adjusted return on assets (ROA). Reported net earnings exhibit volatility, while adjusted net earnings show a more consistent, though initially declining, trend. Total assets, both reported and adjusted, generally increased over the five-year period, with a notable jump in reported total assets in 2024.
- Reported ROA
- Reported ROA began at 9.40% in 2021, decreased to 9.31% in 2022, and then experienced a more substantial decline to 7.82% in 2023. A significant increase was observed in 2024, reaching 16.46%, before falling back to 7.52% in 2025. This fluctuation suggests a sensitivity to changes in reported net earnings and total assets, with the 2024 spike likely driven by the substantial increase in reported net earnings that year.
- Adjusted ROA
- Adjusted ROA followed a similar, though less dramatic, pattern. It decreased from 8.87% in 2021 to 8.55% in 2022 and further to 7.28% in 2023. A modest increase to 7.47% occurred in 2024, followed by a more pronounced rise to 8.86% in 2025. The adjusted ROA appears more stable than the reported ROA, potentially indicating the impact of accounting adjustments smoothing out earnings volatility.
- Relationship between Reported and Adjusted ROA
- The difference between reported and adjusted ROA remained relatively consistent across the period, generally ranging between 0.53% and 1.18%. This suggests that the adjustments made to net earnings and total assets have a predictable, though not insignificant, impact on the overall ROA calculation. The larger difference in 2024 coincides with the largest difference in reported and adjusted net earnings.
- Asset Trends
- Both reported and adjusted total assets experienced a gradual decline from 2021 to 2023. However, reported total assets increased significantly in 2024, while adjusted total assets showed a more moderate increase. This divergence suggests that the adjustments to total assets are mitigating the full impact of asset growth as reflected in the reported figures. Continued growth in both asset measures is observed in 2025.
In summary, the financial performance, as indicated by ROA, demonstrates a period of volatility, particularly in reported earnings. While both reported and adjusted ROA experienced fluctuations, the adjusted figures appear to provide a more stable representation of underlying profitability. The increase in assets in later years, coupled with the changes in net earnings, significantly impacted the ROA values.